A case of idiopathic hypereosinophilic syndrome with leptomeningeal dissemination and intraventricular mass lesion: An autopsy report

Clinical Neuropathology

Volumn 28, Issue 3, 2009, Pages 197-202

  Kanamori, M ^a   Suzuki, H ^b   Sato, I ^a   Ohyama, K ^c   Tezuka, F ^b   Katakura, R ^a  

^a Miyagi Cancer Center   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c TOHOKU ROSAI HOSPITAL   (Japan)

Author keywords

Hypereosinophilic syndrome; Leptomeningeal dissemination; Ventricular mass lesion

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; AUTOPSY; BRAIN VENTRICLE TUMOR; CASE REPORT; CELL INFILTRATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; EOSINOPHIL; EOSINOPHILIA; FEMALE; HEARING DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; LEPTOMENINX; LYMPHOCYTE; MACROPHAGE; MEDULLA OBLONGATA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; SUBARACHNOID SPACE; TUMOR LOCALIZATION; BRAIN DISEASE; FATALITY; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; OTITIS MEDIA; PATHOLOGY; PATHOPHYSIOLOGY; RADIOTHERAPY;

ADRENAL CORTEX HORMONES; ADULT; AUTOPSY; BRAIN DISEASES; FATAL OUTCOME; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOHISTOCHEMISTRY; LATERAL VENTRICLES; OTITIS MEDIA; RADIOTHERAPY;

EID: 67650306398     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp28197     Document Type: Article

References (20)

1. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG. A tyrosine kinase created by fusion of PDGFA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003; 348: 683-693.
2. Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol. 2004; 35: 1160-1163.
3. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975; 54: 1-27.
4. Durack DT, Ackerman SJ, Loegering DA, Gleich GJ. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci USA. 1981; 78: 5165-5169.
5. Gambacorti-Passerini C, Donati MB, Semeraro N, Cofrancesco E, Cortellaro M. Monocyte procoagulant activity in hypereosinophilic syndrome. Lancet. 1983; 2: 460-461.
6. Gambacorti-Passerini C, Passerini C, Cortellaro M, Cofrancesco E, Boschetti C, Pogliani E, Alessio G, Semeraro N, Mussoni L, Donati MB. Possible mechanisms of fibrin deposition in the hypereosinophilic syndrome. Haemostasis. 1989; 19: 32-37.
7. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med. 1968; 68: 1220-1229.
8. Hyman HL, Jarrold T. Eosinophilic leukemia: report of a case with autopsy. Ann Intern Med. 1952; 36: 1541-1547.
9. Klion AD, Noel P, Akin C, LawMA, GillilandDG,Cools J, Metcalfe DD, Nutman TB. Elevated serum tryptase levels identify a subset of patientswith amyeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis and imatinib responsiveness. Blood. 2003; 101: 4660-4666.
10. Kwon SU, Kim JC, Kim JS. Sequential magnetic resonance imaging findings in hypereosinophilia-induced encephalopathy. J Neurol. 2000; 248: 279-284.
11. McMillan HJ, Johnston DL, Doja A. Watershed infarction due to acute hypereosinophilia. Neurology. 2008; 70: 80-82.
12. Roufosse F, Bartholomé E, Schandené L, Goldman M, Cogan E. The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategies. Drugs Today (Barc). 1998; 34: 361-373.
13. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med. 2003; 54: 169-184.
14. Roufosse F, Cogan E, Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy. 2004; 59: 673-689.
15. Sanderson CJ. Interleukin-5, eosinophils and disease. Blood. 1992; 79: 3101-3109.
16. Sano K, Kobayashi M, Sakaguchi N, Ito M, Hotchi M, Matsumoto K. A rat model of hypereosinophilic syndrome. Pathol Int. 2001; 51: 82-88.
17. Sarazin M, Caumes E, Cohen A, Amarenco P. Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosomamansoni infestation. J Neurol Neurosurg Psychiatry. 2004; 75: 305-307.
18. Weingarten JS, O'Sheal SF, Margolis WS. Eosinophilic meningitis and the hypereosinophilic syndrome. Case report and review of the literature. Am J Med. 1985; 78: 674-676.
19. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994; 83: 2759-2779.
20. Wilkins HJ, Crane MM, Copeland K, Williams WV. Hypereosinophilic syndrome: an update. Am J Hematol. 2005; 80: 148-157.